Emerging evidence-based approaches to reduce residual atherosclerotic risk - ask the experts.
Session:
Emerging evidence-based approaches to reduce residual atherosclerotic risk - Ask the experts
Topic:
Secondary Prevention
Sponsored by Novartis Pharma AG
Event:
ESC Congress 2018
Congress Presentation
About the speakers
Doctor Paul M Ridker
Brigham and Women's Hospital, Boston (United States of America)
34
presentations
3
followers
Professor Alberico Catapano
IRCCS - MultiMedica, Milan (Italy)
46
presentations
3
followers
Access the full session
Emerging evidence-based approaches to reduce residual atherosclerotic risk - Ask the experts
Speakers:
Doctor P. Ridker, Professor A. Catapano
About the event
ESC 365 is supported by
